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Abstract
Purpose of the Study: The Disease Burden Morbidity Assessment (DBMA) is a self-report questionnaire in which partici-
pants rate the disease burden caused by a number of medical conditions. This paper studies the measurement properties of 
the DBMA, using Rasch analysis.
Design and Methods: We used data of 1,400 community-dwelling adults aged 50 years and older participating in the 
Ageing in Spain Longitudinal Study, Pilot Survey (ELES-PS). Test of fit to the Rasch model, reliability, unidimensionality, 
response dependency, category structure, scale targeting, and differential item functioning (DIF) were studied in an iterative 
way. Construct validity of the linear measure provided by the Rasch analysis was subsequently assessed.
Results: To achieve an adequate fit to the Rasch model, all items were rescored by collapsing response categories. Reliability 
(Person Separation Index) was low. The scale was unidimensional and neither response dependency nor relevant DIF were 
found. The linear measure had a correlation of −0.48 with physical functioning, −0.47 with perceived health, 0.32 with 
depression, and −0.24 with quality of life (QoL) and displayed satisfactory known-groups validity by sex and age groups. 
Relative precision analysis showed that the linear measure discriminated better between age groups than the original raw 
score, but for sex no difference was found.
Implications: Despite some limitations, support was found for the validity of the DBMA in older adults. Its linear scores 
may be useful to assess strategies aimed at improving the QoL of patients with multimorbidity. More research is needed in 
a hospital-based sample.
Keywords:  Burden of Illness, Chronic disease, Comorbidity
The ageing of populations is a global phenomenon (Beard, 
Officer, & Cassels, 2016). In 1950, the worldwide propor-
tion of persons aged 60 years and older was 8% (United 
Nations, Department of Economic and Social Affairs, 
Population Division, 2013). This percentage rose to almost 
12% in the year 2013, and is expected to reach 21% in the 
year 2050. In high-income countries, these rates are even 
higher, with almost 23% in the year 2013 and a prediction 
of 32% for the year 2050. As a consequence, the preva-
lence of multimorbidity, that is, the presence of multiple 
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coexisting chronic conditions in one person, will also con-
tinue to increase (Gijsen et al., 2001). Multimorbidity is a 
worldwide health problem with well-described associations 
with mortality, complications of treatment, health care 
utilization, and a negative effect on quality of life (QoL) 
(Barnett et al., 2012; Fortin et al., 2004; Gijsen et al., 2001; 
Sangha, Stucki, Liang, Fossel, & Katz, 2003). It requires a 
different health care approach, with a more holistic view of 
patients instead of treating single diseases (Fortin, Stewart, 
Poitras, Almirall, & Maddocks, 2012).
There are different tools to assess multimorbidity, and 
the choice of instrument depends on the methodology and 
outcomes of the investigation (Bayliss, Ellis, & Steiner, 
2009). Several studies have shown the importance of 
assessing subjective disease severity when studying multi-
morbidity, especially in relation to QoL outcomes (Byles, 
D’Este, Parkinson, O’Connell, & Treloar, 2005; Crabtree, 
Gray, Hildreth, O’Connell, & Brown, 2000; Sangha et al., 
2003). Therefore, Bayliss, Ellis, and Steiner (2005) created 
a patient-reported outcome measure in which patients 
select chronic conditions from a list and then rate their 
impact on everyday activities as a measure of disease sever-
ity. This was conceptualized as self-reported disease bur-
den. Disease burden can be defined as the impact of disease 
events on various dimensions of human life (Pinheiro, Plaß, 
& Krämer, 2011), in this case the subjective interference 
with daily activities. The tool was subsequently denomi-
nated the Disease Burden Morbidity Assessment (DBMA) 
by Poitras, Fortin, Hudon, Haggerty, and Almirall (2012).
After an initial validation according to the classical test 
theory, including an exploratory factor analysis (Wijers 
et al., 2016), an additional step in the validation process 
would be an analysis following the item response theory. 
The aim of this study was to perform this through a Rasch 
analysis (Rasch, 1980). Rasch analysis allows us to study 
scale attributes such as unidimensionality, response cat-
egory ordering, local independence of items, item bias by 
specific groups, and scale targeting, and provides a linear 
measure, which, given an appropriate distribution, permits 
the use of parametric statistics (Forjaz et al., 2012).
Methods
Study Design and Sample
Data came from the Ageing in Spain Longitudinal Study, Pilot 
Survey (ELES-PS), which included 1,747 community-dwelling 
adults aged 50 or more, living in Spain (Teófilo Rodríguez, 
González Cabezas, Díaz Veiga, & Rodríguez Rodríguez, 
2011). For the sampling, stratified clusters of census sections 
were randomly selected by autonomous region and municipal-
ity, proportionally to their population of 50 years and older. 
Households with a telephone line were selected at random 
from a commercial household telephone directory. Per house-
hold, individuals aged 50 or more were randomly selected, 
with post-stratification by sex and age group (50–59, 60–69, 
70–79, and 80–89 years). Field work was conducted in 2011.
The data in the ELES-PS study were collected in four 
stages: a telephone questionnaire (n = 1,747), a visit by a 
trained nurse (n  =  1,531), a Computer-Assisted Personal 
Interviewing (CAPI) questionnaire (n = 1,400), and a self-
administered questionnaire (n = 1,145). DBMA data were 
collected through the CAPI questionnaire, and its 1,400 
participants formed the sample that was used for the cur-
rent study. For the Rasch analysis, a random subsample of 
300 was taken, since analysis with samples larger than 300 
could result in statistically significant deviations from the 
Rasch model of otherwise well-fitting items (Linacre, 1994, 
2016; Mavranezouli, Brazier, Young, & Barkham, 2011; 
Smith, Rush, Fallowfield, Velikova, & Sharpe, 2008).
Descriptive statistics of sociodemographic data and 
applied rating scales of the total sample and the subsample 
are displayed in Table 1. Mean age of the participants in the 
total sample was 65.5 (standard deviation [SD] = 10.40) 
years, and 55.36% of them were women. The mean num-
ber of self-reported diseases was 2.5 (SD  =  2.25), and a 
mean raw DBMA score of 5.29 (SD = 6.39) was found.
Assessments
The DBMA, first described by Bayliss and colleagues (2005), 
consists of a self-report questionnaire in which participants 
rate the disease burden caused by a number of medical con-
ditions, if present. Patients are asked to what extent condi-
tions interfere with daily activities, on a 5-point scale from 
1 (not at all) to 5 (a lot). Conditions not present are scored 
zero. We adapted the list of conditions included by Bayliss 
and colleagues by selecting 21 common chronic conditions, 
according to their use in other multimorbidity indexes 
(Bayliss et  al., 2005; Byles et  al., 2005; Fried, Bandeen-
Roche, Kasper, & Guralnik, 1999; Groll, To, Bombardier, 
& Wright, 2005; Sangha et al., 2003). More detailed infor-
mation about how the 21 included conditions were selected 
may be found elsewhere (Wijers et al., 2016).
To measure physical functioning, a 24-item list of dif-
ferent basic and instrumental activities of daily living, as 
used in the Health and Retirement Study (Bendayan et al., 
2016), was applied. Participants were asked whether they 
experience difficulties when performing these activities on 
a scale from 1 (always) to 4 (never). Higher scores indicate 
better physical functioning.
A dichotomous, self-administered 10-item Center for 
Epidemiologic Studies-Depression (CES-D) scale was used 
to screen for depression cases (scores of 3+) (Robison, 
Gruman, Gaztambide, & Blank, 2002). Previous studies 
found support for this short version of the CES-D to be 
as reliable as the original CES-D, with a Cronbach’s alpha 
of 0.80, and to show satisfactory convergent validity with 
the Composite International Diagnostic Interview (sensitiv-
ity and specificity of 84% and 64%, respectively) (Irwin, 
Artin, & Oxman, 1999; Robison et al., 2002).
For QoL, the CAPI questionnaire contained the Personal 
Wellbeing Index (PWI) (The International Wellbeing Group, 
The Gerontologist, 2017, Vol. 00, No. 002
Copyedited by: AM
Downloaded from https://academic.oup.com/gerontologist/article-abstract/doi/10.1093/geront/gnx061/3813315/Rasch-Analysis-and-Construct-Validity-of-the
by Instituto de Economía y Geografía user
on 11 October 2017
2013). This scale consists of seven life dimensions rated on 
a 1–10 scale. Total scores were linearly transformed into a 
0–100 scale, higher scores indicating better QoL. Previous 
research found support for the validity and reliability of 
this linear measure in older adults, correlating moderately 
with “satisfaction with life” and showing a PSI of 0.91 
(Forjaz et al., 2012). The dimension “personal health” of 
the PWI was used as a measure of perceived health.
Statistical Analysis
Rasch analysis was performed using RUMM 2030. 
Differences between thresholds were not expected to be 
equal across items, so the Masters Partial Credit polyto-
mous model was chosen (Masters, 1982), which was con-
firmed by a significant likelihood ratio statistic. Test of fit 
to the Rasch model, reliability, unidimensionality, response 
dependency, category structure, scale targeting, and dif-
ferential item functioning (DIF) were studied in an itera-
tive way, making model modifications until a good fit was 
achieved (Tennant & Conaghan, 2007).
Fit to the Rasch model was tested by comparing the 
observed data with the theoretical item performance 
according to the Rasch model. The item–trait interaction 
statistic, reported as a chi-square, needs to be nonsignifi-
cant (Tennant & Conaghan, 2007). Item and person sum-
mary fit statistics should follow a normal distribution with 
a mean and SD of approximately 0 and 1, respectively. 
Individual item and person standardize fit residuals should 
be within the ±2.5 range and chi-square differences for 
items and persons should be nonsignificant with Bonferroni 
correction for number of items (Pallant & Tennant, 2007).
Reliability was determined with the Person Separation 
Index (PSI), which is interpreted similarly to Cronbach’s 
coefficient alpha: a minimum value of 0.70 for group com-
parisons is recommended (Tennant & Conaghan, 2007). 
The PSI was also obtained in RUMM2020 since algo-
rithms derived from this program provide reliability results 
less influenced by extreme values, missing data, and floor 
and ceiling effects than those obtained with RUMM2030 
(Forjaz et al., 2015).
Unidimensionality was tested through a Principal 
Component Analysis (PCA) of the residuals (Smith et al., 
2006). This test defines two subsets of items, those posi-
tively and those negatively correlated with the first residual 
factor, and the difference in these estimates for each person 
are compared with a t test. The percentage of significant t 
tests should not exceed 5% (Tennant & Conaghan, 2007).
Response dependency was assessed through the residual 
correlation index and a correlation of >0.30 was taken as 
an indication of local dependency (Forjaz et  al., 2012). 
Category structure was explored through category prob-
ability curves, and in case of disordered thresholds, items 
were rescored by collapsing adjacent categories. Scale tar-
geting was assessed through visual inspection of the per-
son–item map, showing the distribution of persons and 
items along the construct.
DIF examines whether different groups within the sam-
ple, despite of equal levels of the characteristic being meas-
ured, respond in a different manner to an individual item 
(Tennant & Pallant, 2007). We studied DIF for age (<65 
vs ≥65 years, which was the median value in our sample), 
sex, and educational level (primary school or less vs more 
than primary school). DIF analysis was performed through 
an analysis of variance (ANOVA) with Bonferroni cor-
rection. In case DIF was identified, this was further ana-
lyzed through a top-down purification approach. In this 
approach, items are divided into two groups, according to 
the presence of absence of DIF, and these are applied as 
Table 1. Characteristics of the Study Sample (n = 1,400) and 
Rasch Analysis Subsample (n = 300)
Total sample Subsample
 N (%)  N (%)
Characteristic (range)  Mean ± SD  Mean ± SD
Sex
 Men 625 (44.64) 132 (44.00)
 Women 775 (55.36) 168 (56.00)
Age (years) 65.50 ± 10.40 64.96 ± 10.27
Education
 Less than primary 480 (34.30) 98 (32.67)
 Primary 313 (22.40) 77 (25.67)
 Secondary 298 (21.30) 61 (20.33)
 University 309 (22.10) 64 (21.33)
Living area
 <10.000 inhabitants 315 (22.50) 70 (23.33)
  10.000–100.000 
inhabitants
502 (35.90) 103 (34.33)
  100.000–500.000 
inhabitants
385 (27.50) 90 (30.33)
 >500.000 inhabitants 198 (14.10) 37 (12.33)
Marital status
 Single 75 (5.36) 17 (5.67)
 Married/living with partner 1014 (72.43) 225 (75.00)
 Widowed 244 (17.43) 44 (14.67)
 Divorced/separated 67 (4.80) 14 (4.67)
CES-Da
 Depression 297 (21.21) 78 (26.00)
 No depression 797 (56.93) 160 (53.33)
 Missing 306 (21.86) 62 (20.67)
PWI (0–100) 74.94 ± 11.09 73.34 ± 12.52
Satisfaction with health 
(0–10)
7.19 ± 3.92 6.84 ± 1.91
Physical functioning (24–96) 91.06 ± 9.56 90.65 ± 10.10
Number of self-reported 
conditions (0–21)
2.50 ± 2.25 2.61 ± 2.29
DBMA raw score (0–105) 5.29 ± 6.39 5.36 ± 6.19
Note: CES-D  =  Center for Epidemiologic Studies-Depression scale; 
DBMA = Disease Burden Morbidity Assessment; PWI = Personal Wellbeing 
Index; SD = standard deviation.
aCutoff point: 3 out of 10.
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two testlets (or superitems). If the superitem formed by the 
items with DIF does not present DIF, then DIF is considered 
to cancel out (Tennant, Penta, et al., 2004).
Once fit to the Rasch model was achieved, disease bur-
den scores of the total sample were used to calculate a lin-
ear measure, on a logit scale, which was converted into a 
0–47 range through a linear transformation. In order to 
compare the subsample of 300 and the rest of the sample 
(n = 1,100), a paired-sample t test was done, comparing the 
logit estimation of the two samples (300 vs 1,100) for each 
raw score. Anchor values of the sample of 300 were used to 
fix item estimations of the other sample. In addition, a DIF 
analysis with the sample as a factor was performed.
Psychometric attributes of the linear measure according 
to the classical test theory were analyzed using Stata 12 ver-
sion for Windows: mean-to-median differences (criterion, 
<10%), floor and ceiling effects (<15%), and skewness (−1 
to 1) were calculated for acceptability (Virués-Ortega et al., 
2010). Construct validity was assessed through known-
groups validity for sex and age (<65 vs  ≥  65  years) and 
convergent validity with other health outcomes. We hypoth-
esized to find higher disease burden scores for women 
(Barnett et al., 2012) and in the highest age group (Global 
Burden of Disease Study 2013 Collaborators, 2015), which 
was studied with a Wilcoxon rank-sum test due to the non-
normal distribution of the linear measure. For convergent 
validity, we calculated Spearman’s rank correlations with 
physical functioning, depression (CES-D total score), QoL 
(PWI), and perceived health (PWI item 2: personal health). 
Moderate to high correlations (r  >  0.30) were expected 
(Cohen, 1988).
We performed a relative precision analysis in order to 
assess how much more or less precise the Rasch-based 
score is relative to the raw summative-based score in distin-
guishing groups expected to differ (Las Hayas et al., 2011). 
This was done for sex and age groups (<65 vs ≥ 65 years). 
Relative precision was calculated as the ratio of pairwise 
Z statistics (the linear measure Z statistic divided by the 
raw score Z statistic) (Sakthong, Charoenvisuthiwongs, & 
Shabunthom, 2008), and a bootstrap method was applied 
in order to obtain confidence intervals (CIs) for relative 
precision statistics (Fitzpatrick et al., 2004). Rasch analysis 
takes into account observations with missing values when 
calculating the linear measure. In order to be able to calcu-
late the relative precision, the studied sample sizes should 
be equal, thus observations with missing values were 
excluded in the latter analysis.
Results
Rasch Analysis
The initial analysis, with the whole study sample, displayed 
poor fit to the Rasch model (Table 2). After selecting a sub-
sample of 300, the fit indices improved, but still did not 
meet the fit criteria. Category probability curves showed 
disordered thresholds, so items were rescored to two (two 
items), three (13 items), four (five items), or five catego-
ries (one item) (Table  3). After this, the DBMA showed 
an acceptable fit to the Rasch model (Table 2). Individual 
item and person fit residuals were within the −2.5 to +2.5 
range, with nonsignificant chi-squares (Table 3). However, 
PSI remained low, 0.272. When repeating this estimation 
in RUMM2020, the PSI improved to 0.637. In the PCA 
of the residuals, 0.72% of tests were outside the previ-
ously set range, indicating unidimensionality. All items 
were locally independent, with a residual correlation index 
ranging 0.000–0.188. No DIF was found for age or educa-
tional level. Four items showed DIF by sex of small mag-
nitude (<0.5 logits): item 1 (hypertension), 14 (anxiety), 
17 (osteoporosis), and 21 (urinary tract problems). In the 
top-down purification approach, this DIF was no longer 
present. The person–item threshold distribution (Figure 1) 
showed a floor effect and no persons represented the scale’s 
higher levels of disease burden. Also, there were very 
few persons located around the highest point of the test 
information curve.
DBMA scores of the total sample were converted into a 
linear measure from 0 to 47 (see Supplementary Material). 
When comparing the subsample of 300 and the rest of 
the sample, no significant differences between the estima-
tions were found (difference = 0.259 logits, t test = 1.226, 
p value = .226), and no DIF was observed by sample.
Classic Psychometric Analysis of the Linear 
Measure
Mean score of the linear measure was 7.36 (SD = 5.01), 
median score 7.44, with a mean–median difference of 
0.17%. Floor effect for the total scale was 18.11%, with no 
ceiling effect, and skewness was 0.046. The linear measure 
presented a correlation of −0.48 with physical functioning, 
−0.47 with perceived health, 0.32 with depression (CES-
D), and −0.24 with the PWI (p < .001). Women scored 
significantly higher than men, with mean scores of 8.14 
(SD = 5.15) and 6.40 (SD = 4.65), respectively (p < .001), 
and scores increased with age: mean score among persons 
<65 years was 5.93 (SD = 4.76) versus a mean score of 8.77 
(SD = 4.84) in persons aged ≥65 years (p < .001). The results 
of the relative precision analysis are shown in Table 4. The 
ability to discriminate between age groups increased by 9% 
when using the linear measure versus the raw score (95% 
CI: 1.03–1.17), but precision decreased 4% for age groups, 
although this difference was not statistically significant 
(95% CI: 0.86–1.05).
Discussion
This study analyzed the measurement properties of the 
DMBA according to the Rasch model. Rasch analysis 
provided knowledge of DBMA psychometric attributes 
that were not previously known. Test of fit to the Rasch 
model was satisfactory after rescoring response options, 
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with all items showing a good fit, and the scale was uni-
dimensional. The residual correlation index did not iden-
tify response dependency, meaning that there were no 
items linked in such way that the response to one item 
would determine the response to another. Furthermore, 
Rasch analysis provided a linear measure, which allows 
calculation of change scores and, given a normal distri-
bution, the use of parametric statistics (Hobart, Cano, 
Zajicek, & Thompson, 2007; Tennant, McKenna, & 
Hagell, 2004).
In order to achieve an adequate fit to the Rasch model, 
items needed to be rescored. This might have been due to 
too many response categories, which could have prevented 
people from making fine distinctions between rating scale 
steps. In most cases, response options were reduced to three 
categories. This reduction in response categories does not 
Table 2. Global Fit to the Rasch Model of the DBMA Using the Total Sample (n = 1,400), After Selecting a Subsample (n = 300) 
and After Rescoring the Response Scale
Standard Total sample Subsample After rescoring
Item fit residual Mean 0 −2.90 −1.12 −0.68
SD 1 1.83 0.77 0.71
Person fit residual Mean 0 −0.48 −0.42 −0.28
SD 1 0.59 0.58 0.55
Item–trait interaction χ2 Low 316.33 165.14 154.43
Prob. NS <.001 .89 .32
PSI >0.70 0.07 0.14 0.27
Unidimensionality Significant t tests (%) <5 0.72 2.00 2.00
Note: DBMA = Disease Burden Morbidity Assessment; NS = nonsignificant; Prob. = probability; PSI = Person Separation Index; SD = standard deviation. Item 
fit residual refers to the difference between the data observed and the expected values at item level. Person fit refers to the difference between the data observed 
and the expected values at person level. Item–trait interaction is a chi-square value and probability resulting from the comparison between the expected and the 
mean observed score for groups of people with similar ability estimates. PSI is a reliability measure. Unidimensionality refers to the existence of one measurement 
construct (dimension) underlying the set of items.
Table 3. Threshold Ordering of Polytomous Items and Individual Item Fit to the Rasch Model After Rescoring (n = 300)
Original categories
Individual item fit to the Rasch model0 1 2 3 4 5
Item Rescored categories Location SE Residual χ2 Prob.
Osteoarthritis 0 1 1 1 2 3 −1.914 0.093 −2.020 14.737 .040
Rheumatoid arthritis 0 1 1 1 2 3 −1.514 0.108 −1.749 5.988 .541
Chronic back pain 0 1 1 1 1 2 −1.392 0.130 −0.707 10.910 .143
Depression 0 1 1 1 1 2 −1.161 0.140 −0.996 7.631 .366
Circulation problems/intermittent claudication 0 1 1 1 2 3 −0.965 0.134 −1.698 5.237 .631
Hypertension 0 1 2 2 3 4 −0.934 0.088 −0.515 16.122 .024
Anxiety 0 1 1 1 1 2 −0.858 0.160 −1.474 7.290 .399
Osteoporosis 0 1 1 1 1 2 −0.644 0.162 −1.271 3.796 .803
Cancer 0 1 1 1 2 3 −0.515 0.160 0.068 8.254 .311
Diabetes 0 1 1 1 1 2 −0.371 0.174 −0.637 6.877 .442
Heart failure 0 1 1 1 1 2 −0.331 0.196 −0.055 8.192 .316
Urinary tract problems (prostate, bladder) 0 1 1 1 2 3 −0.219 0.147 −0.436 6.327 .502
COPD/emphysema 0 1 1 1 1 2 −0.137 0.222 −0.162 5.471 .603
Cerebral embolism/stroke 0 1 1 1 1 1 0.296 0.353 0.171 10.195 .178
Memory disorders 0 1 1 1 1 1 0.310 0.355 −0.424 5.818 .561
Gastric/duodenal ulcer 0 1 1 1 1 2 1.081 0.199 0.849 9.992 .189
Kidney disease 0 1 1 1 1 2 1.190 0.218 −0.444 7.298 .399
Asthma 0 1 1 1 1 2 1.578 0.274 −1.258 5.272 .627
Myocardial infarction 0 1 1 1 1 2 1.685 0.296 −0.340 2.781 .904
Angina 0 1 1 1 1 2 2.039 0.473 −0.312 4.173 .760
Parkinson’s disease 0 1 1 2 2 2 2.776 0.924 −0.912 2.071 .956
Note: COPD = chronic obstructive pulmonary disease; Prob. = probability; SE = standard error. Items are ordered by increasing difficulty (mean location of 
thresholds).
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require changing the original questionnaire. Instead, it 
may be performed when calculating the total scores, thus 
avoiding using different response categories that could 
be confusing to the respondent. It would be interesting 
to study whether simplifying the questionnaire, by reduc-
ing the response categories in the same way for all items, 
would improve the psychometric properties of the DBMA. 
However, this might reduce the scale precision.
Some items displayed DIF by sex, indicating that men 
and women, despite having the same level of burden caused 
by hypertension, anxiety, osteoporosis, or urinary tract 
problems, answered differently to these items. A very strict 
approach would have been to delete these items; however, 
this would have compromised the clinical applicability of 
the scale. Another possibility would be to split the items 
and get different calibrations for men and women (Tennant 
& Conaghan, 2007). This would make the scale more diffi-
cult to score, which, nonetheless, is justifiable if DIF results 
are replicated in further studies. DIF was no longer present 
in the top-down purification analysis, meaning that if DIF 
favors men for one item, to balance women are favored 
for another item. So, for the moment, and taking into con-
sideration that differences were of small magnitude, we 
decided to be conservative and avoid scale modifications 
due to DIF. We do not expect DIF to have influenced the 
sex differences found in this study, since DIF refers to group 
differences at the same construct level.
The high floor effect (and as a consequence, the asym-
metrical person–item threshold distribution) represents 
cases in which participants reported not having certain 
conditions. This implies that the floor effect can actually 
be regarded as an indicator of how “healthy” the studied 
population is. Also, there were very few persons located 
near the highest point of the test information curve, which 
represents the location where the test is the most power-
ful in the sense of measurement precision. These data sug-
gest that the test performance would probably improve in 
a hospital-based sample, with a higher proportion of mul-
timorbid patients and therefore less floor effects and better 
scale targeting; thus, more research is needed.
We found a low reliability in RUMM2030 and although 
the PSI value improved when using RUMM2020, it still 
did not fit the criterion. This effect is probably due to the 
design of the DBMA, in which disease burden is rated for 
single diseases. Experiencing disease burden from one dis-
ease does not imply that a person should have the other 
20 conditions as well, which makes items in this scale less 
related to each other than in other scales. Nevertheless, hav-
ing comorbid conditions does increase the disease burden 
experienced from a specific disease (Gadermann, Alonso, 
Vilagut, Zaslavsky, & Kessler, 2012; Moussavi et al., 2007), 
which might have caused that PSI in RUMM2020, less 
influenced by floor effects than in RUMM2030, was closer 
to the criterion of >0.70. This could also make us expect 
the PSI to be higher in a sample with more multimorbidity. 
Low PSIs were also found in other widely used scales, such 
as the EQ-5D-3D (Pickard, De Leon, Kohlmann, Cella, & 
Rosenbloom, 2007).
Our study showed moderate correlations between the 
linear measure and physical functioning, perceived health, 
and depression and a weak correlation with QoL. Bayliss 
and colleagues (2005) reported high correlations with 
physical functioning and perceived health (−0.63 and 0.60, 
respectively) and a weak correlation (−0.29) with depres-
sion. The higher correlations with the first two outcomes, 
in comparison to our results, could be due to the fact that 
Bayliss’ study population was older, which resulted in a 
higher prevalence of chronic conditions. The floor effect in 
our “healthy” population might have attenuated the rela-
tion between the DBMA and these outcomes. We found a 
slightly higher correlation with depression than Bayliss and 
Table 4. Relative Precision of the Linear Measure in Comparison to the Raw Summative DBMA Score (n = 1,277)
Scoring method Patient groups Mean (SE) Mean difference (SE) Z statistic RP 95% CI
Raw score <65 years 3.81 (0.20) 3.02 (0.35) −9.89 1.00
≥65 years 6.83 (0.28)
Linear measure <65 years 5.95 (0.19) 2.98 (0.26) −10.77 1.09 1.03–1.17
≥65 years 8.92 (0.19)
Raw score Men 3.88 (0.19) 2.59 (0.35) −6.61 1.00
Women 6.47 (0.28)
Linear measure Men 6.43 (0.19) 1.78 (0.27) −6.33 0.96 0.86–1.05
Women 8.21 (0.19)
Note: CI = confidence interval; DBMA = Disease Burden Morbidity Assessment; RP = relative precision; SE = standard error.
Figure  1. Person–item distribution and test information curve: final 
Rasch analysis of the Disease Burden Morbidity Assessment (DBMA).
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colleagues, which can be ascribed to the fact that, unlike 
Bayliss and colleagues, we did include depression in the list 
of conditions used in the DBMA. Depression is a condition 
with a high prevalence and an important cause of disability 
(Ferrari et  al., 2013; Moussavi et  al., 2007). The inverse 
effect also exists: disability itself is an important predictor 
of depression (Bacon et  al., 2016). Therefore, we argued 
that not including depression in the DBMA could underes-
timate disease burden scores. The relative precision analysis 
displayed some gain in precision in discriminating between 
age groups but when discriminating between sex groups, 
no difference was found with the original scale. These data 
suggest that the linear measure is at least as valid as the raw 
summative score concerning discriminant validity.
Some limitations must be acknowledged. We could not 
compare the outcomes of the DBMA with a “gold stand-
ard,” because no other measures of multimorbidity or dis-
ease burden were included in the ELES-PS study. Secondly, 
as mentioned above, we validated a disease burden assess-
ment instrument in a sample with quite a high health status, 
and little multimorbidity and disease burden. The studied 
population consisted of community-dwelling older adults, 
which means that institutionalized persons, with probably 
more multimorbidity, were not included. Also, only persons 
with household telephone lines were selected. The propor-
tion of persons aged 50 years and older in Spain with tel-
ephone lines is estimated to be at least 92% (Rodríguez 
Laso et al., 2013), but it is possible that people that do not 
have a telephone line have lower incomes, which is known 
to be related to lower health status (Katz & Calasanti, 
2015). Moreover, the persons that refused to participate 
in the CAPI interview, the questionnaire that contained 
the DBMA, were of higher age and reported lower per-
ceived health than the respondents who did answer this 
questionnaire (Rodríguez Laso et  al., 2013). Due to the 
relatively high health status, we found a very low PSI, high 
floor effects, and asymmetrical person–item threshold dis-
tribution. A  third limitation was that, like other authors 
(Bayliss et  al., 2009; Hudon, Fortin, Poitras, & Almirall, 
2012; Poitras et al., 2012), we adapted the list of conditions 
included in the DBMA, which hinders comparisons with 
other studies. Further research should include the develop-
ment of a standard list of conditions.
In summary, despite some limitations such as reliability 
below the expected and insufficient scale targeting, sup-
port was found for the validity of the DBMA as a patient-
reported health outcome for measuring disease burden 
caused by 21 common chronic diseases in older adults. Its 
linear measure is related to patient-centered outcomes such 
as QoL and permits the calculation of change scores, mak-
ing it potentially useful for the implementation of strategies 
to improve QoL and functional status among comorbid 
patients. Persons with multimorbidity are progressively 
becoming more common in our health care systems, and 
it is important to assess the impact that patients experi-
ence because of their multimorbidity. The DBMA measures 
the burden of multimorbidity, by asking the respondent to 
rate the impact of diseases on what is most important to 
patients themselves: their everyday life.
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